BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 22406998)

  • 1. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells.
    Kim JW; Jung SY; Kwon YH; Lee JH; Lee YM; Lee BY; Kwon SM
    Cancer Biol Ther; 2012 May; 13(7):504-15. PubMed ID: 22406998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside Rg3 inhibits endothelial progenitor cell differentiation through attenuation of VEGF-dependent Akt/eNOS signaling.
    Kim JW; Jung SY; Kwon YH; Lee SH; Lee JH; Lee BY; Kwon SM
    Phytother Res; 2012 Sep; 26(9):1286-93. PubMed ID: 22253055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decursin inhibits vasculogenesis in early tumor progression by suppression of endothelial progenitor cell differentiation and function.
    Jung SY; Choi JH; Kwon SM; Masuda H; Asahara T; Lee YM
    J Cell Biochem; 2012 May; 113(5):1478-87. PubMed ID: 22298358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The angiosuppressive effects of 20(R)- ginsenoside Rg3.
    Yue PY; Wong DY; Wu PK; Leung PY; Mak NK; Yeung HW; Liu L; Cai Z; Jiang ZH; Fan TP; Wong RN
    Biochem Pharmacol; 2006 Aug; 72(4):437-45. PubMed ID: 16793023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice.
    Liu TG; Huang Y; Cui DD; Huang XB; Mao SH; Ji LL; Song HB; Yi C
    BMC Cancer; 2009 Jul; 9():250. PubMed ID: 19624862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of ginsenoside Rg3 in melanoma through downregulation of the ERK and Akt pathways.
    Meng L; Ji R; Dong X; Xu X; Xin Y; Jiang X
    Int J Oncol; 2019 Jun; 54(6):2069-2079. PubMed ID: 31081060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
    Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
    Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phloroglucinol inhibits the bioactivities of endothelial progenitor cells and suppresses tumor angiogenesis in LLC-tumor-bearing mice.
    Kwon YH; Jung SY; Kim JW; Lee SH; Lee JH; Lee BY; Kwon SM
    PLoS One; 2012; 7(4):e33618. PubMed ID: 22496756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside Rg3 sensitizes human non-small cell lung cancer cells to γ-radiation by targeting the nuclear factor-κB pathway.
    Wang L; Li X; Song YM; Wang B; Zhang FR; Yang R; Wang HQ; Zhang GJ
    Mol Med Rep; 2015 Jul; 12(1):609-14. PubMed ID: 25738799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway.
    Cao Y; Ye Q; Zhuang M; Xie S; Zhong R; Cui J; Zhou J; Zhu Y; Zhang T; Cao L
    PLoS One; 2017; 12(11):e0186520. PubMed ID: 29140979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental study on anti-angiogenesis in mice with Lewis lung carcinoma by low-dose of cyclophosphamide combined with ginsenoside Rg3].
    Kang XM; Zhang QY; Tong DD; Zhao W
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Aug; 25(8):730-3. PubMed ID: 16152834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive antiangiogenesis effect of ginsenoside Rg3 with low-dose metronomic temozolomide on rat glioma cells both in vivo and in vitro.
    Sun C; Yu Y; Wang L; Wu B; Xia L; Feng F; Ling Z; Wang S
    J Exp Clin Cancer Res; 2016 Feb; 35():32. PubMed ID: 26872471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growth.
    Bellou S; Karali E; Bagli E; Al-Maharik N; Morbidelli L; Ziche M; Adlercreutz H; Murphy C; Fotsis T
    Mol Cancer; 2012 May; 11():35. PubMed ID: 22583931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer.
    Xu TM; Xin Y; Cui MH; Jiang X; Gu LP
    Chin Med J (Engl); 2007 Apr; 120(7):584-8. PubMed ID: 17442207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside Rg1 promotes endothelial progenitor cell migration and proliferation.
    Shi AW; Wang XB; Lu FX; Zhu MM; Kong XQ; Cao KJ
    Acta Pharmacol Sin; 2009 Mar; 30(3):299-306. PubMed ID: 19262553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic anti-tumour activity of ginsenoside Rg3 and doxorubicin on proliferation, metastasis and angiogenesis in osteosarcoma by modulating mTOR/HIF-1α/VEGF and EMT signalling pathways.
    Zeng X; Liu S; Yang H; Jia M; Liu W; Zhu W
    J Pharm Pharmacol; 2023 Nov; 75(11):1405-1417. PubMed ID: 37498992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo.
    Tang YC; Zhang Y; Zhou J; Zhi Q; Wu MY; Gong FR; Shen M; Liu L; Tao M; Shen B; Gu DM; Yu J; Xu MD; Gao Y; Li W
    Int J Oncol; 2018 Jan; 52(1):127-138. PubMed ID: 29115601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitory effect of ginsenoside Rg3 on the tube-like structure formation in human nasopharyngeal carcinoma HNE-1 cell line in vitro].
    Wang HB; Lin YC; Zeng D; Lin W; Hong CQ; Lin WZ; Chen JY
    Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):739-42. PubMed ID: 21163062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside Rg3 Inhibition of Thyroid Cancer Metastasis Is Associated with Alternation of Actin Skeleton.
    Wu W; Zhou Q; Zhao W; Gong Y; Su A; Liu F; Liu Y; Li Z; Zhu J
    J Med Food; 2018 Sep; 21(9):849-857. PubMed ID: 30136914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenoside Rg3 alleviates the migration, invasion, and angiogenesis of lung cancer cells by inhibiting the expressions of cyclooxygenase-2 and vascular endothelial growth factor.
    Lv Q; Xia Z; Huang Y; Ruan Z; Wang J; Huang Z
    Chem Biol Drug Des; 2023 Apr; 101(4):937-951. PubMed ID: 36593682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.